[ET Net News Agency, 30 April 2021] Goldman Sachs raised its target price for Wuxi
Apptec (02359) to HK$227.6 from HK$202.3 and maintained its "buy" rating.
The research house said it sees the accelerated 1Q growth further validating its
constructive view on the company as a global pharma/biotech innovation enabler. It views
the strong growth momentum to continue in 2021 and see the company's new capabilities
expansion (e.g. AAC vector suspension platform) to drive mid-to-long term growth. (RC)